Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure
- 1 June 1989
- journal article
- research article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 13 (7), 1534-1539
- https://doi.org/10.1016/0735-1097(89)90344-6
Abstract
No abstract availableThis publication has 33 references indexed in Scilit:
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987
- Clinical determinants of mortality in chronic congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathyThe American Journal of Cardiology, 1987
- Correlation of Left Ventricular Ejection Fraction and Plasma Atrial Natriuretic Peptide in Congestive Heart FailureNew England Journal of Medicine, 1986
- Atrial Natriuretic Peptide and Atrial Pressure in Patients with Congestive Heart FailureNew England Journal of Medicine, 1986
- Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart FailureNew England Journal of Medicine, 1986
- Hemodynamic changes mimicking a vasodilator drug response in the absence of drug therapy after right heart catheterization in patients with chronic heart failure.Circulation, 1985
- Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart FailureNew England Journal of Medicine, 1984
- Factors influencing the one-year mortality of dilated cardiomyopathyThe American Journal of Cardiology, 1984
- Prostaglandins in Severe Congestive Heart FailureNew England Journal of Medicine, 1984
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958